|
 |
|
 |
|
|
Transmucosal Drug
Delivery (OraDisc™) |
|
|
|
|
|
|
|
1 |
2 |
3 |
4 |
5 |
6 |
7 |
|
|
|
|
|
|
|
Development
Status: |
|
|
|
|
|
|
|
Mucoadhesive film
product containing amlexanox for the treatment of aphthous
ulcers has received FDA approval. |
|
|
|
|
|
|
|
- Product
tested in 1,200 patients.
-
2 placebo
controlled efficacy studies.
-
28 days safety
testing.
- Irritation
study.
- 2 year ICH
stability testing.
-
Manufacturing scale-up to 10% of commercial production.
- Commercial
packaging initiated.
|
|
|
|
Mucoadhesive film
product containing benzocaine for the treatment of oral pain
developed in conjunction with a major pharmaceutical company,
ready for production validation. |
|
|
|
|
|
|
|
Prototype products
for oral and systemic applications developed for: |
|
|
|
|
|
|
|
|
|
|
|
Prototype dental
products developed for: |
|
|
|
|
|
|
|
- Erodible tooth whitening strip
-
De-sensitizing strip
- Fluoride
strip
- Remineralization strip
- Disc to reduce salivation
|
|
|
|
1 |
2 |
3 |
4 |
5 |
6 |
7 |
|
|
|
|
|